Hyperglycaemia in patients with acute ischaemic stroke

How often do we screen for undiagnosed diabetes?

Dawn Bravata, N. Kim, J. Concato, L. M. Brass

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Background: Hyperglycaemia is common among patients; with acute ischaemic stroke, and may be due to the physiological stress of the acute stroke event or reflect underlying diabetes mellitus. The under-diagnosis of diabetes in the general population, combined with the association of diabetes and stroke, suggests a rationale for screening for diabetes among hyperglycaemic stroke patients. Aim: To determine how often clinicians screen for diabetes among hyperglycaemic stroke patients without a prior diagnosis of diabetes. Design: Retrospective medical record review. Methods: We reviewed the records of acute ischaemic stroke patients admitted at any of ten Connecticut hospitals from May 1996 through December 1998. Results: We identified 90 acute stroke patients with no prior history of diabetes. The prevalence of hyperglycaemia varied from 31% down to 6%, depending on the maximum glucose cut-off used to define hyperglycaemia: from ≥ 140 mg/dl (7.8 mmol/l) to ≥ 200 mg/dl (11.1 mmol/l). Only one of the hyperglycaemic patients (1/90, 1%) had any evidence that a clinician screened or planned to screen for undiagnosed diabetes: one patient had a haemoglobin A1c measured during the hospitalization, none received oral glucose tolerance testing while hospitalized, and no discharge summary included a plan to screen for diabetes as an out-patient. Discussion: Hyperglycaemic stroke patients without a previous diagnosis of diabetes are not routinely screened for diabetes. This situation represents an opportunity, currently unused, to identify an important and modifiable condition.

Original languageEnglish (US)
Pages (from-to)491-497
Number of pages7
JournalQJM - Monthly Journal of the Association of Physicians
Volume96
Issue number7
StatePublished - Jul 1 2003
Externally publishedYes

Fingerprint

Hyperglycemia
Stroke
Physiological Stress
Glucose Tolerance Test
Medical Records
Diabetes Mellitus
Hemoglobins
Hospitalization
Outpatients
Glucose
Population

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Hyperglycaemia in patients with acute ischaemic stroke : How often do we screen for undiagnosed diabetes? / Bravata, Dawn; Kim, N.; Concato, J.; Brass, L. M.

In: QJM - Monthly Journal of the Association of Physicians, Vol. 96, No. 7, 01.07.2003, p. 491-497.

Research output: Contribution to journalArticle

@article{67c167c0e16e4dac949cc800f0002267,
title = "Hyperglycaemia in patients with acute ischaemic stroke: How often do we screen for undiagnosed diabetes?",
abstract = "Background: Hyperglycaemia is common among patients; with acute ischaemic stroke, and may be due to the physiological stress of the acute stroke event or reflect underlying diabetes mellitus. The under-diagnosis of diabetes in the general population, combined with the association of diabetes and stroke, suggests a rationale for screening for diabetes among hyperglycaemic stroke patients. Aim: To determine how often clinicians screen for diabetes among hyperglycaemic stroke patients without a prior diagnosis of diabetes. Design: Retrospective medical record review. Methods: We reviewed the records of acute ischaemic stroke patients admitted at any of ten Connecticut hospitals from May 1996 through December 1998. Results: We identified 90 acute stroke patients with no prior history of diabetes. The prevalence of hyperglycaemia varied from 31{\%} down to 6{\%}, depending on the maximum glucose cut-off used to define hyperglycaemia: from ≥ 140 mg/dl (7.8 mmol/l) to ≥ 200 mg/dl (11.1 mmol/l). Only one of the hyperglycaemic patients (1/90, 1{\%}) had any evidence that a clinician screened or planned to screen for undiagnosed diabetes: one patient had a haemoglobin A1c measured during the hospitalization, none received oral glucose tolerance testing while hospitalized, and no discharge summary included a plan to screen for diabetes as an out-patient. Discussion: Hyperglycaemic stroke patients without a previous diagnosis of diabetes are not routinely screened for diabetes. This situation represents an opportunity, currently unused, to identify an important and modifiable condition.",
author = "Dawn Bravata and N. Kim and J. Concato and Brass, {L. M.}",
year = "2003",
month = "7",
day = "1",
language = "English (US)",
volume = "96",
pages = "491--497",
journal = "Quarterly Journal of Medicine",
issn = "1460-2725",
publisher = "Oxford University Press",
number = "7",

}

TY - JOUR

T1 - Hyperglycaemia in patients with acute ischaemic stroke

T2 - How often do we screen for undiagnosed diabetes?

AU - Bravata, Dawn

AU - Kim, N.

AU - Concato, J.

AU - Brass, L. M.

PY - 2003/7/1

Y1 - 2003/7/1

N2 - Background: Hyperglycaemia is common among patients; with acute ischaemic stroke, and may be due to the physiological stress of the acute stroke event or reflect underlying diabetes mellitus. The under-diagnosis of diabetes in the general population, combined with the association of diabetes and stroke, suggests a rationale for screening for diabetes among hyperglycaemic stroke patients. Aim: To determine how often clinicians screen for diabetes among hyperglycaemic stroke patients without a prior diagnosis of diabetes. Design: Retrospective medical record review. Methods: We reviewed the records of acute ischaemic stroke patients admitted at any of ten Connecticut hospitals from May 1996 through December 1998. Results: We identified 90 acute stroke patients with no prior history of diabetes. The prevalence of hyperglycaemia varied from 31% down to 6%, depending on the maximum glucose cut-off used to define hyperglycaemia: from ≥ 140 mg/dl (7.8 mmol/l) to ≥ 200 mg/dl (11.1 mmol/l). Only one of the hyperglycaemic patients (1/90, 1%) had any evidence that a clinician screened or planned to screen for undiagnosed diabetes: one patient had a haemoglobin A1c measured during the hospitalization, none received oral glucose tolerance testing while hospitalized, and no discharge summary included a plan to screen for diabetes as an out-patient. Discussion: Hyperglycaemic stroke patients without a previous diagnosis of diabetes are not routinely screened for diabetes. This situation represents an opportunity, currently unused, to identify an important and modifiable condition.

AB - Background: Hyperglycaemia is common among patients; with acute ischaemic stroke, and may be due to the physiological stress of the acute stroke event or reflect underlying diabetes mellitus. The under-diagnosis of diabetes in the general population, combined with the association of diabetes and stroke, suggests a rationale for screening for diabetes among hyperglycaemic stroke patients. Aim: To determine how often clinicians screen for diabetes among hyperglycaemic stroke patients without a prior diagnosis of diabetes. Design: Retrospective medical record review. Methods: We reviewed the records of acute ischaemic stroke patients admitted at any of ten Connecticut hospitals from May 1996 through December 1998. Results: We identified 90 acute stroke patients with no prior history of diabetes. The prevalence of hyperglycaemia varied from 31% down to 6%, depending on the maximum glucose cut-off used to define hyperglycaemia: from ≥ 140 mg/dl (7.8 mmol/l) to ≥ 200 mg/dl (11.1 mmol/l). Only one of the hyperglycaemic patients (1/90, 1%) had any evidence that a clinician screened or planned to screen for undiagnosed diabetes: one patient had a haemoglobin A1c measured during the hospitalization, none received oral glucose tolerance testing while hospitalized, and no discharge summary included a plan to screen for diabetes as an out-patient. Discussion: Hyperglycaemic stroke patients without a previous diagnosis of diabetes are not routinely screened for diabetes. This situation represents an opportunity, currently unused, to identify an important and modifiable condition.

UR - http://www.scopus.com/inward/record.url?scp=0038156954&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038156954&partnerID=8YFLogxK

M3 - Article

VL - 96

SP - 491

EP - 497

JO - Quarterly Journal of Medicine

JF - Quarterly Journal of Medicine

SN - 1460-2725

IS - 7

ER -